A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera

International Immunology

Volumn 13, Issue 7, 2001, Pages 959-967

  Hock, Barry D ^a   Kato, Masato ^b   McKenzie, Judith L ^a   Hart, Derek N J ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

CD83; Dendritic cell; Soluble

Indexed keywords

CD83 ANTIGEN; GLYCOPROTEIN; LIGAND;

ANTIGEN PURIFICATION; ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; BLOOD DONOR; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINE; CELL POPULATION; CIRCULATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HODGKIN DISEASE; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SERUM; SOLUBILITY; TONSIL; WESTERN BLOTTING;

EID: 0034925541     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/13.7.959     Document Type: Article

References (38)

1. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily
2. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily
3. Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype
4. Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1
5. Dendritic cells and the control of immunity
6. Dendritic cells: Unique leukocyte populations which control the primary immune response
7. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: Implications for studies on antigen-presenting cell function and immunotherapy
8. Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56
9. + dendritic cells
10. Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells
11. Membrane proteins with soluble counterparts: Role of proteolysis in the release of transmembrane proteins
12. Soluble receptors for cytokines and growth factors: Generation and biological function
13. Soluble cytokine receptors
14. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells
15. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth
16. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
17. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes
18. Crosslinking of the human Fc receptor for IgA (FcalphaRI/CD89) triggers FcR gamma-chain-dependent shedding of soluble CD89
19. Circulating adhesion molecules in disease
20. Existence of a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte activation. Present in normal human serum and levels are increased in the serum of systemic lupus erythematosus patients
21. The PI-linked receptor FcRIII is released on stimulation of neutrophils
22. Induction of membrane-associated and soluble CD83 from B, T and dendritic cells
23. Human T lymphocytes and hematopoietic cell lines express CD24-associated carbohydrate epitopes in the absence of CD24 mRNA or protein
24. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes
25. Biotinylation: An alternative to radioiodination for the identification of cell surface antigens in immunoprecipitates
26. Determination of monoclonal antibody specificity by immunoadsorption and western blotting
27. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells
28. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes
29. B lymphocytes secrete antigen-presenting vesicles
30. 2+ mobilization, while basal release is predominantly the product of differential mRNA splicing in THP-1 cells
31. Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes
32. Regulation of ICAM-3 (CD50) membrane expression on human neutrophils through a proteolytic shedding mechanism
33. Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation
34. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias
35. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
36. The soluble interleukin-2 receptor: Biology, function, and clinical application
37. Downregulation of Fas ligand by shedding
38. Hodgkin's cells express CD83, a dendritic cell lineage associated antigen